Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivian Tsai

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 26, 2024
Important antimicrobial dosing considerations for transitions of care: Focus on thrice-weekly dosing in hemodialysisY Vivian Tsai, Caitlin Soto, Garrett Crawford, et al.
Circulation. Heart Failure|April 7, 2011
Characteristics and outcomes of very elderly patients after first hospitalization for heart failureRashmee U Shah, Vivian Tsai, Liviu Klein, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 2, 2007
Cardiac device infections complicated by erosionVivian Tsai, Henry Chen, Henry Hsia, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2011
Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United StatesVivian Tsai, Mary K Goldstein, Henry H Hsia, et al.
Pharmacy (Basel, Switzerland)|November 21, 2023
Application of Precision Medicine Concepts in Ambulatory Antibiotic Management of Acute PyelonephritisMorgan Pizzuti, Yuwei Vivian Tsai, Hana R Winders, et al.
Journal of the American Geriatrics Society|September 3, 2011
Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individualsVivian Tsai, Mary K Goldstein, Henry H Hsia, et al.
Heart Rhythm|May 19, 2015
Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD RegistryDaniel W Kaiser, Vivian Tsai, Paul A Heidenreich, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Epidemiology, Outcomes and Tolerability of Protracted Treatment of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United StatesYuwei Vivian Tsai, Caroline Derrick, Ismaeel Yunusa, et al.
American Heart Journal|August 25, 2015
A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placementPaul A Heidenreich, Vivian Tsai, Jeptha Curtis, et al.
JACC. Heart Failure|May 19, 2015
Does Age Influence Cardiac Resynchronization Therapy Use and Outcome?Paul A Heidenreich, Vivian Tsai, Haikun Bao, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 26, 2024
Important antimicrobial dosing considerations for transitions of care: Focus on thrice-weekly dosing in hemodialysisY Vivian Tsai, Caitlin Soto, Garrett Crawford, et al.
Circulation. Heart Failure|April 7, 2011
Characteristics and outcomes of very elderly patients after first hospitalization for heart failureRashmee U Shah, Vivian Tsai, Liviu Klein, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 2, 2007
Cardiac device infections complicated by erosionVivian Tsai, Henry Chen, Henry Hsia, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2011
Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United StatesVivian Tsai, Mary K Goldstein, Henry H Hsia, et al.
Pharmacy (Basel, Switzerland)|November 21, 2023
Application of Precision Medicine Concepts in Ambulatory Antibiotic Management of Acute PyelonephritisMorgan Pizzuti, Yuwei Vivian Tsai, Hana R Winders, et al.
Journal of the American Geriatrics Society|September 3, 2011
Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individualsVivian Tsai, Mary K Goldstein, Henry H Hsia, et al.
Heart Rhythm|May 19, 2015
Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD RegistryDaniel W Kaiser, Vivian Tsai, Paul A Heidenreich, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Epidemiology, Outcomes and Tolerability of Protracted Treatment of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United StatesYuwei Vivian Tsai, Caroline Derrick, Ismaeel Yunusa, et al.
American Heart Journal|August 25, 2015
A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placementPaul A Heidenreich, Vivian Tsai, Jeptha Curtis, et al.
JACC. Heart Failure|May 19, 2015
Does Age Influence Cardiac Resynchronization Therapy Use and Outcome?Paul A Heidenreich, Vivian Tsai, Haikun Bao, et al.
Pageof 2